Purine, 6-bromo- → HCID 178448888, compound
Reaction equation
[CH3:1][C:2]1[CH:11]=[CH:10][CH:9]=[C:8]2[C:3]=1[C:4](=[O:32])[N:5]([C:26]1[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=1)[C:6]([CH:12]([NH:16][C:17]1[N:25]=[CH:24][N:23]=[C:22]3[C:18]=1[N:19]=[CH:20][NH:21]3)[CH2:13][C:14]#[CH:15])=[N:7]2.[NH2:33]C1N=C2C(NC=N2)=C(Br)N=1.BrC1N=CN=C2C=1NC=N2>>[NH2:33][C:24]1[N:23]=[C:22]2[C:18]([N:19]=[CH:20][NH:21]2)=[C:17]([NH:16][CH:12]([C:6]2[N:5]([C:26]3[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=3)[C:4](=[O:32])[C:3]3[C:8](=[CH:9][CH:10]=[CH:11][C:2]=3[CH3:1])[N:7]=2)[CH2:13][C:14]#[CH:15])[N:25]=1Participants
4
Procedure
Compound 165 was prepared following the general procedure described above for the preparation of compound 161, but 2-amino-6-bromopurine was substituted for 6-bromopurine in step D. ESI-MS m/z=437 (MH+).
Sources & evidence
- ORD record
- ord-45fc52e7cab64f6a8dfeb53636a61d30
- Source dataset
- uspto-grants-2013_12
- Patent number
- USRE044638E1
Reaction notes
Loading…